Adjuvant pretreatment with alum protects neonatal mice in sepsis through myeloid cell activation

Clinical and Experimental Immunology

Volumn 191, Issue 3, 2018, Pages 268-278

  Rincon, J C ^a   Cuenca, A L ^a   Raymond, S L ^a   Mathias, B ^a   Nacionales, D C ^a   Ungaro, R ^a   Efron, P A ^a   Wynn, J L ^a   Moldawer, L L ^a   Larson, S D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

alum; neonatal sepsis; NETs; phagocytosis

Indexed keywords

ALUMINUM POTASSIUM SULFATE; B7 ANTIGEN; CASPASE 11; CD86 ANTIGEN; IMJECT; INFLAMMASOME; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LEUKOCYTE ELASTASE; PHORBOL ESTER DERIVATIVE; RAG1 PROTEIN; ALUMINUM SULFATE; BACTERIAL VACCINE; CASP11 PROTEIN, MOUSE; CASPASE; IMMUNOLOGICAL ADJUVANT;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BONE MARROW CELL; CELL ACTIVATION; CELL PHAGOCYTOSIS; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; EXTRACELLULAR TRAP; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; INNATE IMMUNITY; MONOCYTE; MOUSE; MYELOPOIESIS; NEUTROPHIL; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; STEM CELL EXPANSION; SURVIVAL; T LYMPHOCYTE; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL SELF-RENEWAL; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHAGOCYTOSIS; PHYSIOLOGY; SEPSIS;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANIMALS, NEWBORN; B-LYMPHOCYTES; BACTERIAL VACCINES; CASPASE 1; CASPASES; CELL SELF RENEWAL; DISEASE MODELS, ANIMAL; EXTRACELLULAR TRAPS; HUMANS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NEUTROPHILS; PHAGOCYTOSIS; SEPSIS; T-LYMPHOCYTES;

EID: 85034250713     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.13072     Document Type: Article

References (41)

1. Liu L, Johnson HL, Cousens S et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151–61.
2. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6:S3–5.
3. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553–64.
4. Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010; 37:439–79.
5. Gentile LF, Nacionales DC, Lopez MC et al. Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol 2014; 192:3156–65.
6. Kollmann TR, Crabtree J, Rein-Weston A et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009; 183:7150–60.
7. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532–5.
8. Yost CC, Cody MJ, Harris ES et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood 2009; 113:6419–27.
9. Marcos V, Nussbaum C, Vitkov L et al. Delayed but functional neutrophil extracellular trap formation in neonates. Blood 2009; 114:4908–11.
10. Erdman SH, Christensen RD, Bradley PP, Rothstein G. Supply and release of storage neutrophils. A developmental study. Biol Neonate 1982; 41:132–7.
11. Carr R. Neutrophil production and function in newborn infants. Br J Haematol 2000; 110:18–28.
12. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379–90.
13. Ulas T, Pirr S, Fehlhaber B et al. S100-alarmin-induced innate immune programming protects newborn infants from sepsis. Nat Immunol 2017; 18:622–32.
14. Wynn JL, Scumpia PO, Winfield RD et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008; 112:1750–8.
15. Lindblad EB. Aluminium compounds for use in vaccines. Immunol Cell Biol 2004; 82:497–505.
16. De Gregorio E, Tritto E, Rappuoli R. Alum adjuvanticity: unraveling a century old mystery. Eur J Immunol 2008; 38:2068–71.
17. Flach TL, Ng G, Hari A et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med 2011; 17:479–87.
18. Oleszycka E, Moran HB, Tynan GA et al. IL-1alpha and inflammasome-independent IL-1beta promote neutrophil infiltration following alum vaccination. FEBS J 2016; 283:9–24.
19. Wynn JL, Scumpia PO, Delano MJ et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 2007; 28:675–83.
20. Gentile LF, Cuenca AL, Cuenca AG et al. Improved emergency myelopoiesis and survival in neonatal sepsis by caspase-1/11 ablation. Immunology 2015; 145:300–11.
21. Sarkar A, Hall MW, Exline M et al. Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med 2006; 174:1003–10.
22. Vorobjeva NV, Pinegin BV. Effects of the antioxidants Trolox, Tiron and Tempol on neutrophil extracellular trap formation. Immunobiology 2016; 221:208–19.
23. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453:1122–6.
24. Said-Sadier N, Ojcius DM. Alarmins, inflammasomes and immunity. Biomed J 2012; 35:437–49.
25. Nolan A, Weiden M, Kelly A et al. CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Resp Crit Care Med 2008; 177:301–8.
26. Cuenca AG, Cuenca AL, Gentile LF et al. Delayed emergency myelopoiesis following polymicrobial sepsis in neonates. Innate Immun 2015; 21:386–91.
27. Sutterwala FS, Ogura Y, Szczepanik M et al. Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase- 1. Immunity 2006; 24:317–27.
28. Chen KW, Bezbradica JS, Groß CJ et al. The murine neutrophil NLRP3 inflammasome is activated by soluble but not particulate or crystalline agonists. Eur J Immunol 2016; 46:1004–10.
29. Kuroda E, Coban C, Ishii KJ. Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol 2013; 32:209–20.
30. Kool M, Soullie T, van Nimwegen M et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008; 205:869–82.
31. Marichal T, Ohata K, Bedoret D et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 2011; 17:996–1002.
32. Sokolovska A, Becker CE, Ip WK et al. Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function. Nat Immunol 2013; 14:543–53.
33. McKee AS, Munks MW, MacLeod MK et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 2009; 183:4403–14.
34. Oh DY, Dowling DJ, Ahmed S et al. Adjuvant-induced human monocyte secretome profiles reveal adjuvant- and age-specific protein signatures. Mol Cell Proteomics 2016; 15:1877–94.
35. Kool M, Petrilli V, De Smedt T et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008; 181:3755–9.
36. Anderson DC, Freeman KL, Heerdt B, Hughes BJ, Jack RM, Smith CW. Abnormal stimulated adherence of neonatal granulocytes: impaired induction of surface Mac-1 by chemotactic factors or secretagogues. Blood 1987; 70:740–50.
37. Tunc T, Cekmez F, Cetinkaya M et al. Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis. J Matern Fetal Neonatal Med 2015; 28:356–61.
38. Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med 2004; 199:47–58.
39. Gartner F, Alt FW, Monroe RJ, Seidl KJ. Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice. J Exp Med 2000; 192:1745–54.
40. Engle WD, Rosenfeld CR. Neutropenia in high-risk neonates. J Pediatr 1984; 105:982–6.
41. Gessler P, Luders R, Konig S, Haas N, Lasch P, Kachel W. Neonatal neutropenia in low birthweight premature infants. Am J Perinatol 1995; 12:34–8.